PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding

Clinical trial NCT00562198 · TERMINATED

Trial details

NCT number: NCT00562198
Sponsor: Orion Corporation, Orion Pharma
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson´s Disease

Start date: 2008-01-01
Primary completion: 2008-02-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.